VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome

This study has been terminated.
(Lack of efficacy)
Information provided by (Responsible Party):
Anthera Pharmaceuticals Identifier:
First received: April 19, 2010
Last updated: October 30, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
No publications provided by Anthera Pharmaceuticals

Publications automatically indexed to this study by Identifier (NCT Number):